CN Stock MarketDetailed Quotes

000963 Huadong Medicine

Watchlist
  • 32.94
  • -0.03-0.09%
Market Closed Apr 30 15:00 CST
57.79BMarket Cap19.62P/E (TTM)

Huadong Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
2.93%10.41B
7.71%40.62B
9.10%30.39B
12.02%20.39B
13.23%10.11B
9.12%37.71B
7.45%27.86B
5.93%18.2B
0.40%8.93B
2.61%34.56B
Operating revenue
2.93%10.41B
7.71%40.62B
9.10%30.39B
12.02%20.39B
13.23%10.11B
9.12%37.71B
7.45%27.86B
5.93%18.2B
0.40%8.93B
2.61%34.56B
Other operating revenue
----
60.37%362.43M
----
50.97%137.47M
----
55.26%226M
----
93.76%91.06M
----
84.66%145.56M
Total operating cost
2.42%9.33B
7.27%37.08B
8.33%27.54B
11.67%18.44B
13.49%9.11B
8.96%34.57B
7.17%25.42B
5.61%16.52B
0.26%8.03B
3.46%31.73B
Operating cost
4.21%7.08B
6.93%27.46B
8.97%20.71B
13.67%13.92B
14.81%6.79B
7.20%25.68B
6.66%19.01B
5.64%12.24B
1.89%5.91B
6.24%23.96B
Operating tax surcharges
5.99%56.33M
11.65%232.59M
6.38%155.06M
11.03%106.69M
6.58%53.15M
17.53%208.32M
10.37%145.77M
8.46%96.08M
4.57%49.87M
-4.43%177.25M
Operating expense
-4.16%1.57B
4.90%6.65B
3.53%4.66B
1.68%3.08B
14.59%1.64B
16.79%6.33B
8.12%4.5B
1.82%3.03B
-13.04%1.43B
-9.15%5.42B
Administration expense
1.54%335.17M
13.73%1.42B
15.33%1.11B
26.12%721.48M
9.08%330.09M
7.01%1.25B
11.50%958.82M
6.99%572.05M
9.03%302.6M
16.84%1.17B
Financial expense
-74.08%7.56M
-34.59%51.19M
230.55%64.03M
925.12%55.85M
261.66%29.15M
254.50%78.26M
21.84%19.37M
-44.35%5.45M
-5.52%8.06M
-35.45%22.08M
-Interest expense (Financial expense)
-33.12%23.05M
-6.38%119.51M
51.30%84.32M
32.55%55.4M
64.47%34.47M
44.10%127.65M
-7.05%55.73M
12.31%41.8M
-0.93%20.96M
29.06%88.59M
-Interest Income (Financial expense)
-95.41%-24.41M
9.00%-94.05M
18.60%-61.68M
33.90%-33.02M
48.30%-12.49M
-28.54%-103.35M
-16.85%-75.78M
-29.93%-49.96M
-26.79%-24.16M
-31.83%-80.4M
Research and development
6.08%281.64M
25.08%1.27B
6.68%840.79M
-1.45%558.41M
-16.83%265.49M
3.71%1.02B
8.32%788.16M
29.49%566.6M
45.09%319.21M
5.71%979.64M
Credit Impairment Loss
----
62.49%-25.76M
41.61%-42.02M
49.38%-36.43M
----
-64.76%-68.69M
-88.08%-71.97M
-88.08%-71.97M
----
-82.64%-41.69M
Asset Impairment Loss
----
-70.60%-6.52M
---3.18M
---3.18M
----
77.40%-3.82M
----
--0
----
-272.63%-16.91M
Other net revenue
85.10%-7.36M
-5.18%-88.94M
-196.03%-146.45M
-306.01%-143.26M
-195.02%-49.37M
-528.20%-84.56M
-179.02%-49.47M
-173.70%-35.28M
-133.40%-16.73M
-95.70%19.75M
Fair value change income
---25.36K
-148.32%-13.76M
---6.62M
---5.1M
----
--28.47M
----
----
----
----
Invest income
23.63%-47.16M
-55.21%-219.71M
-70.25%-168.84M
-155.96%-136.89M
-120.85%-61.75M
-46.98%-141.56M
-65.28%-99.17M
1.80%-53.48M
-4.86%-27.96M
-249.90%-96.31M
-Including: Investment income associates
28.99%-37.5M
-62.94%-188.39M
-79.47%-145.31M
-179.12%-120.43M
-154.37%-52.82M
-116.38%-115.62M
-326.81%-80.97M
-88.80%-43.15M
-79.75%-20.76M
-393.57%-53.43M
Asset deal income
169.15%1.52M
-47.69%4.32M
-35.68%3.59M
-58.62%3.52M
-494.37%-2.2M
26,209.73%8.26M
3,819.50%5.58M
4,566.05%8.51M
83.29%557.82K
-100.01%-31.63K
Other revenue
162.72%38.31M
85.91%172.49M
-39.17%70.62M
-57.36%34.81M
36.68%14.58M
-46.89%92.78M
-26.51%116.09M
-40.56%81.65M
-86.05%10.67M
-9.02%174.69M
Operating profit
12.39%1.07B
12.79%3.45B
13.49%2.71B
9.25%1.8B
7.46%953.94M
7.20%3.06B
5.18%2.39B
3.63%1.65B
-5.49%887.72M
-17.86%2.86B
Add:Non operating Income
-6.74%1.3M
564.38%50.55M
-29.74%3.54M
-31.53%2.97M
67.05%1.39M
183.66%7.61M
-71.13%5.03M
420.03%4.34M
145.63%831.62K
-78.54%2.68M
Less:Non operating expense
-13.99%5.2M
-1.18%37.49M
-11.34%24M
88.17%16.3M
12.94%6.05M
22.93%37.94M
36.11%27.07M
41.37%8.66M
77.11%5.36M
-13.51%30.86M
Total profit
12.53%1.07B
14.35%3.47B
13.68%2.69B
8.73%1.79B
7.48%949.28M
7.20%3.03B
4.32%2.36B
3.70%1.64B
-5.70%883.19M
-18.12%2.83B
Less:Income tax cost
9.82%207.94M
24.29%619.59M
38.06%494.56M
19.91%345.28M
11.94%189.35M
1.96%498.5M
10.41%358.22M
19.61%287.94M
4.32%169.16M
-10.07%488.91M
Net profit
13.20%860.25M
12.39%2.85B
9.33%2.19B
6.35%1.44B
6.43%759.93M
8.30%2.53B
3.30%2.01B
0.85%1.35B
-7.80%714.03M
-19.63%2.34B
Net profit from continuing operation
13.20%860.25M
12.39%2.85B
9.33%2.19B
6.35%1.44B
6.43%759.93M
8.30%2.53B
3.30%2.01B
0.85%1.35B
-7.80%714.03M
-19.63%2.34B
Less:Minority Profit
-146.68%-2.17M
-77.44%7.54M
-81.89%4.5M
-54.77%6.03M
-52.00%4.64M
-9.69%33.41M
-46.88%24.85M
-68.37%13.33M
-39.93%9.67M
-58.83%37M
Net profit of parent company owners
14.18%862.41M
13.59%2.84B
10.48%2.19B
6.96%1.43B
7.23%755.28M
8.58%2.5B
4.54%1.98B
3.09%1.34B
-7.12%704.36M
-18.38%2.3B
Earning per share
Basic earning per share
14.20%0.4929
13.55%1.6219
10.47%1.251
6.96%0.8194
7.23%0.4316
8.58%1.4283
4.54%1.1324
3.10%0.7661
-7.13%0.4025
-18.37%1.3154
Diluted earning per share
14.21%0.4928
13.47%1.6207
10.41%1.2503
6.91%0.819
7.20%0.4315
8.58%1.4283
4.54%1.1324
3.10%0.7661
-7.13%0.4025
-18.37%1.3154
Other composite income
229.47%40.59M
223.84%50.51M
79.56%-3.89M
90.95%-8.89M
-108.80%-31.35M
-69.40%-40.78M
-116.46%-19.03M
-298.24%-98.25M
-112.62%-15.01M
-23.02%-24.08M
Other composite income of parent company owners
229.47%40.59M
223.84%50.51M
79.56%-3.89M
90.95%-8.89M
-108.80%-31.35M
-69.40%-40.78M
-116.46%-19.03M
-298.24%-98.25M
-112.62%-15.01M
-23.02%-24.08M
Total composite income
23.64%900.84M
16.26%2.9B
10.18%2.19B
13.96%1.43B
4.23%728.57M
7.66%2.49B
-3.43%1.99B
-9.80%1.26B
-21.76%699.02M
-19.92%2.31B
Total composite income of parent company owners
24.74%903M
17.53%2.89B
11.35%2.19B
14.70%1.42B
5.02%723.93M
7.94%2.46B
-2.41%1.96B
-7.97%1.24B
-21.43%689.35M
-18.67%2.28B
Total composite income of minority owners
-146.68%-2.17M
-77.44%7.54M
-81.89%4.5M
-54.77%6.03M
-52.00%4.64M
-9.69%33.41M
-46.88%24.85M
-68.37%13.33M
-39.93%9.67M
-58.83%37M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 2.93%10.41B7.71%40.62B9.10%30.39B12.02%20.39B13.23%10.11B9.12%37.71B7.45%27.86B5.93%18.2B0.40%8.93B2.61%34.56B
Operating revenue 2.93%10.41B7.71%40.62B9.10%30.39B12.02%20.39B13.23%10.11B9.12%37.71B7.45%27.86B5.93%18.2B0.40%8.93B2.61%34.56B
Other operating revenue ----60.37%362.43M----50.97%137.47M----55.26%226M----93.76%91.06M----84.66%145.56M
Total operating cost 2.42%9.33B7.27%37.08B8.33%27.54B11.67%18.44B13.49%9.11B8.96%34.57B7.17%25.42B5.61%16.52B0.26%8.03B3.46%31.73B
Operating cost 4.21%7.08B6.93%27.46B8.97%20.71B13.67%13.92B14.81%6.79B7.20%25.68B6.66%19.01B5.64%12.24B1.89%5.91B6.24%23.96B
Operating tax surcharges 5.99%56.33M11.65%232.59M6.38%155.06M11.03%106.69M6.58%53.15M17.53%208.32M10.37%145.77M8.46%96.08M4.57%49.87M-4.43%177.25M
Operating expense -4.16%1.57B4.90%6.65B3.53%4.66B1.68%3.08B14.59%1.64B16.79%6.33B8.12%4.5B1.82%3.03B-13.04%1.43B-9.15%5.42B
Administration expense 1.54%335.17M13.73%1.42B15.33%1.11B26.12%721.48M9.08%330.09M7.01%1.25B11.50%958.82M6.99%572.05M9.03%302.6M16.84%1.17B
Financial expense -74.08%7.56M-34.59%51.19M230.55%64.03M925.12%55.85M261.66%29.15M254.50%78.26M21.84%19.37M-44.35%5.45M-5.52%8.06M-35.45%22.08M
-Interest expense (Financial expense) -33.12%23.05M-6.38%119.51M51.30%84.32M32.55%55.4M64.47%34.47M44.10%127.65M-7.05%55.73M12.31%41.8M-0.93%20.96M29.06%88.59M
-Interest Income (Financial expense) -95.41%-24.41M9.00%-94.05M18.60%-61.68M33.90%-33.02M48.30%-12.49M-28.54%-103.35M-16.85%-75.78M-29.93%-49.96M-26.79%-24.16M-31.83%-80.4M
Research and development 6.08%281.64M25.08%1.27B6.68%840.79M-1.45%558.41M-16.83%265.49M3.71%1.02B8.32%788.16M29.49%566.6M45.09%319.21M5.71%979.64M
Credit Impairment Loss ----62.49%-25.76M41.61%-42.02M49.38%-36.43M-----64.76%-68.69M-88.08%-71.97M-88.08%-71.97M-----82.64%-41.69M
Asset Impairment Loss -----70.60%-6.52M---3.18M---3.18M----77.40%-3.82M------0-----272.63%-16.91M
Other net revenue 85.10%-7.36M-5.18%-88.94M-196.03%-146.45M-306.01%-143.26M-195.02%-49.37M-528.20%-84.56M-179.02%-49.47M-173.70%-35.28M-133.40%-16.73M-95.70%19.75M
Fair value change income ---25.36K-148.32%-13.76M---6.62M---5.1M------28.47M----------------
Invest income 23.63%-47.16M-55.21%-219.71M-70.25%-168.84M-155.96%-136.89M-120.85%-61.75M-46.98%-141.56M-65.28%-99.17M1.80%-53.48M-4.86%-27.96M-249.90%-96.31M
-Including: Investment income associates 28.99%-37.5M-62.94%-188.39M-79.47%-145.31M-179.12%-120.43M-154.37%-52.82M-116.38%-115.62M-326.81%-80.97M-88.80%-43.15M-79.75%-20.76M-393.57%-53.43M
Asset deal income 169.15%1.52M-47.69%4.32M-35.68%3.59M-58.62%3.52M-494.37%-2.2M26,209.73%8.26M3,819.50%5.58M4,566.05%8.51M83.29%557.82K-100.01%-31.63K
Other revenue 162.72%38.31M85.91%172.49M-39.17%70.62M-57.36%34.81M36.68%14.58M-46.89%92.78M-26.51%116.09M-40.56%81.65M-86.05%10.67M-9.02%174.69M
Operating profit 12.39%1.07B12.79%3.45B13.49%2.71B9.25%1.8B7.46%953.94M7.20%3.06B5.18%2.39B3.63%1.65B-5.49%887.72M-17.86%2.86B
Add:Non operating Income -6.74%1.3M564.38%50.55M-29.74%3.54M-31.53%2.97M67.05%1.39M183.66%7.61M-71.13%5.03M420.03%4.34M145.63%831.62K-78.54%2.68M
Less:Non operating expense -13.99%5.2M-1.18%37.49M-11.34%24M88.17%16.3M12.94%6.05M22.93%37.94M36.11%27.07M41.37%8.66M77.11%5.36M-13.51%30.86M
Total profit 12.53%1.07B14.35%3.47B13.68%2.69B8.73%1.79B7.48%949.28M7.20%3.03B4.32%2.36B3.70%1.64B-5.70%883.19M-18.12%2.83B
Less:Income tax cost 9.82%207.94M24.29%619.59M38.06%494.56M19.91%345.28M11.94%189.35M1.96%498.5M10.41%358.22M19.61%287.94M4.32%169.16M-10.07%488.91M
Net profit 13.20%860.25M12.39%2.85B9.33%2.19B6.35%1.44B6.43%759.93M8.30%2.53B3.30%2.01B0.85%1.35B-7.80%714.03M-19.63%2.34B
Net profit from continuing operation 13.20%860.25M12.39%2.85B9.33%2.19B6.35%1.44B6.43%759.93M8.30%2.53B3.30%2.01B0.85%1.35B-7.80%714.03M-19.63%2.34B
Less:Minority Profit -146.68%-2.17M-77.44%7.54M-81.89%4.5M-54.77%6.03M-52.00%4.64M-9.69%33.41M-46.88%24.85M-68.37%13.33M-39.93%9.67M-58.83%37M
Net profit of parent company owners 14.18%862.41M13.59%2.84B10.48%2.19B6.96%1.43B7.23%755.28M8.58%2.5B4.54%1.98B3.09%1.34B-7.12%704.36M-18.38%2.3B
Earning per share
Basic earning per share 14.20%0.492913.55%1.621910.47%1.2516.96%0.81947.23%0.43168.58%1.42834.54%1.13243.10%0.7661-7.13%0.4025-18.37%1.3154
Diluted earning per share 14.21%0.492813.47%1.620710.41%1.25036.91%0.8197.20%0.43158.58%1.42834.54%1.13243.10%0.7661-7.13%0.4025-18.37%1.3154
Other composite income 229.47%40.59M223.84%50.51M79.56%-3.89M90.95%-8.89M-108.80%-31.35M-69.40%-40.78M-116.46%-19.03M-298.24%-98.25M-112.62%-15.01M-23.02%-24.08M
Other composite income of parent company owners 229.47%40.59M223.84%50.51M79.56%-3.89M90.95%-8.89M-108.80%-31.35M-69.40%-40.78M-116.46%-19.03M-298.24%-98.25M-112.62%-15.01M-23.02%-24.08M
Total composite income 23.64%900.84M16.26%2.9B10.18%2.19B13.96%1.43B4.23%728.57M7.66%2.49B-3.43%1.99B-9.80%1.26B-21.76%699.02M-19.92%2.31B
Total composite income of parent company owners 24.74%903M17.53%2.89B11.35%2.19B14.70%1.42B5.02%723.93M7.94%2.46B-2.41%1.96B-7.97%1.24B-21.43%689.35M-18.67%2.28B
Total composite income of minority owners -146.68%-2.17M-77.44%7.54M-81.89%4.5M-54.77%6.03M-52.00%4.64M-9.69%33.41M-46.88%24.85M-68.37%13.33M-39.93%9.67M-58.83%37M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg